Point72 Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.1M Buy
25,100
+9,400
+60% +$1.45M 0.01% 1836
2025
Q4
$2.73M Buy
+15,700
New +$2.86M ﹤0.01% 2291
2024
Q3
Sell
-40,200
Closed -$2.69M 2163
2024
Q2
$2.69M Sell
40,200
-19,000
-32% -$737K 0.01% 1008
2024
Q1
$1.61M Hold
59,200
﹤0.01% 1337
2023
Q4
$1.83M Buy
+59,200
New +$1.54M ﹤0.01% 1237

Other funds holding INSM

Point72 Asset Management's INSM Position: Q4 2025 in Review

Point72 Asset Management sold out of Insmed (INSM) in Q4 2025, closing a stake of 464,217 shares — an estimated $84.7M sold.

Point72 Asset Management first reported a position in INSM in Q2 2014 and held it in 29 quarters. The position peaked at $98.9M in Q3 2021. 677 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • Point72 Asset Management reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
  • Point72 Asset Management sold 464,217 Insmed shares in Q4 2025, an estimated $84.7M.
  • Point72 Asset Management first reported a position in Insmed in Q2 2014 and held it in 29 quarters.
  • Point72 Asset Management's Insmed position peaked at $98.9M in Q3 2021.
  • 677 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Point72 Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.